David Nassif Insider Profile
4 Followers
David Nassif, CFO / CLO at Pharvaris, holds 113.80K shares in Pharvaris (Ticker: PHVS), holds 45.24K shares in Sio Gene Therapies (Ticker: SIOX), holds 0.00 shares in Steadymed (Ticker: STDY).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+11.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO / CLO
Roles that David Nassif holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Nassif
David Nassif's Trading History
Pharvaris
Sep 23, 2026
CFO / CLO
Uninformative Sell
―
$3.64M
Steadymed
Sep 04, 2018
―
Uninformative Sell
98.82K
$0.00
Sio Gene Therapies
Dec 09, 2021
―
Uninformative Buy
―
$21.63K
List of latest transactions for each holding click on a transaction to see David Nassif's performance on stock
You May Also Like
David Nassif insider profile FAQ
What is the percentage of profitable transactions made by David Nassif?
The percentage of profitable transactions made by David Nassif is 100%.
What is the average return per transaction made by David Nassif?
The average return per transaction made by David Nassif is 11.60%.
What stocks does David Nassif hold?
David Nassif holds: PHVS, STDY, SIOX stocks.
What was David Nassif’s latest transaction?
David Nassif latest transaction was an Uninformative Sell of ―.
What was David Nassif's most profitable transaction?
David Nassif’s most profitable transaction was an Informative Sell of PHVS stock on September 23, 2026. The return on the trade was 16.10%.
What is David Nassif's role in Pharvaris?
David Nassif's role in Pharvaris is CFO / CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.